TAZIN MAHNAJ
** ****** ****, *******, ** *****
Contacts: 845-***-****
*******@***.***
SUMMARY
R&D scientist experienced in method development and validation in the pharmaceutical
industry. Provides support to the group in developing and validating analytical methods
based on scientific knowledge and experience, ensuring that all critical parameters are
included in executing method validation activities. Expertise in solving problems,
developing value-added techniques for raw materials, finished products and innovative
products to support the formulation and product development group. Writes protocols
and specifications based on USP, ICH or other compendial or regulatory requirements.
Write analytical reports using correct language and terminology. S trong instrumental
skills, Participate in instrument troubleshooting and conducting Out-of-Specification
(“OOS”) investigations, in accordance with current regulatory guidelines and laws. Self
motivated and worked independently in multiple projects in fast paced team
environment.
TECHNICAL SKILLS/ KNOWLEDGE
Extensive knowledge and hands-on experience to run samples following the analytical
instrumentation: HPLC, UV/VIS, FTIR, KF and GC. Working knowledge in UPLC, LC-
MS, GC-MS, GPC and NMR
Design preformulation experiments involved characterization techniques such as: XRD,
DSC, TGA, SDT, IMC &Hot Stage Microscopy, SEM, DMA and Particle size Analyzer
PROFESSIONAL EXPERIENCE
Post doctoral research involved synthesis and characterization of new silicon based
hybrid inorganic/organic polymers, at William Paterson University, Wyane, NJ (2011-
Present)
Senior Scientist Teva/Barr Pharmaceuticals (2005–2010)
● Audit a variety of methodologies in analytical R&D areas as applied to various stages
of pharmaceutical development. Audits, and reviews laboratory data generated by the
group. Verify accuracy of data into reports, and evaluate the stability results and trend
for regulatory requirements.
● Internal laboratory audits, discuss issues with lab as discovered during final report
auditing, identifying potential compliance issues, finding of laboratory investigations,
deviations and implements corrective actions to prevent them. Monitoring the internal
quality systems to ensure compliance with FDA
● Audit Instrument calibration to ensure accurate readings, train others in SOP’s, non-
conformances, internal and external corrective and preventive action plans, e nsure
release of numerous FDA approved products timely to meet deadlines and response of
FDA comment letters using precise analytical skills to meet paragraph IV requirements
● In-depth knowledge of USP, BP, ICH, GLP, FDA, DEA requirements and responsible
for adherence to Federal, OSHA regulations, cGMP’s, SOP’s and company policies and
procedures
Page 1
Tazin Mahnaj
Method Development Scientist Barr Pharmaceuticals
(1997- 2005)
● Performed development of analytical methods for drug substances and finished
products. Validate of analytical methods to provide supports for
formulation and development groups and transfer activities of assigned
projects
● Experienced in analytical method validation for dissolution, potency, related
compounds, residual solvents and stability indicating methods for raw materials and
finished products and compare equivalency with the reference listed drugs
● Performed vendor’s method qualification, raw material release, bio-equivalency in-
vitro dissolution profiles for immediate and extended release products to support the
formulation group and co-ordinate the product development activities of innovated drug
products
● Experienced in process validation for scale up and bio/submission batches to release
results of new products. Performed cleaning method validation for manufacturing
equipment’s to meet the acceptance and validity criteria
● In-house standard qualification and calibration of analytical instruments like HPLC,
UPLC, GC, LC-MS, Dissolution apparatus, UV-VIS. Conduct instrument troubleshooting
and capable of troubleshooting analytical methods
● Performed stability testing for R&D products and monitored stability results and
identify trends for ANDA submission . Assist quality control department to modify and
improve existing methods and performed analytical test method transfer to QC
department
● Authored and executed method validation protocols, reports, standard operation
procedure and regulatory submission documents for different products. Prepare ANDA
stability reports, coordinate and manage analytical documentations to support the CMC
section of regulatory submissions
EDUCATION
Ph.D. in Pharmaceutical Sciences (2010), Arnold & Marie Schwartz College of
Pharmacy and Health Sciences, Long Island University, NY
Thesis: “Study the Effect of Various Chemical Groups of Plasticizers on the Ethyl
Cellulose Polymer Film for Evaluating their Plasticizing Efficiency”
M.S in Chemistry (1991) Department of Chemistry, University of Dhaka, Bangladesh
Thesis: “Adsorption of Polyvinyl Alcohol from aqueous solution of Attapulgide clay
colloid”
B.S in Chemistry (1989) Department of Chemistry, University of Dhaka, Bangladesh
Page 2
Tazin Mahnaj
PROFESSIONAL DEVELOPMENT
● Ph. D Research: Physical characterization of ethyl cellulose polymer and polymeric
films with different plasticizers.
● Evaluate the physical properties of pharmaceutical solids using XRD, DSC, TGA
FTIR, SEM and DMA techniques Long Island University (2006 –2009)
● Research Assistant/Tutor in the Department of Pharmaceutical Sciences/ Academic
Reinforcement Center Long Island University (1993 – 1997)
PRESENTATION AND PUBLICATIONS
H. Ahmed, T. Mahnaj and R.J Mannan. “Adsorption of PVA from Aqueous solution of
Attapulgide clay colloid” was published on Dhaka University Studies, B 37(1)75-81,
1989
T. Mahnaj, S.U. Ahmed and F.M. Plakogiannis. “Evaluating the efficacy of a group of
nontraditional plasticizers on the glass transition temperature of ethyl cellulose polymer”
in Drug Development and Industrial pharmacy, March 2011, Vol. 37, No. 3, Pages 342-
350 (doi:10.3109/03639045.2010.513390)
T. Mahnaj, S.U. Ahmed, R.H. Dave and F. M. Plakogiannis. “Effect of Various Groups of
Plasticizers on Ethyl Cellulose Film” Journal of applied polymer science- under review
T. Mahnaj, S.U. Ahmed and F.M. Plakogiannis “Characterization of Ethyl Cellulose
Polymer”. Pharmaceutical Development and Technology – under review
T. Mahnaj, S.U. Ahmed and F. M. Plakogiannis. “Plasticizing Performance of
Tricarboxylic Acid Derivatives: Effect on Glass Transition Temperatures” Manuscript to
be submitted
PROFESSIONAL AFFILIATIONS
● American Association of Pharmaceutical Scientists (AAPS) 2004–Present
● American Chemical Society (ACS) 2008- Present
Page 3
Tazin Mahnaj